Link Between Rheumatoid Arthritis & Lung Disease

Trial Objective

Link Between Rheumatoid Arthritis and Lung DiseaseThe purpose of this study is to determine the development and progression of rheumatoid arthritis -associated lung disease (RA-LD) over time and to learn about the body’s generation of auto-antibodies in the blood. Researchers are trying to understand who develops rheumatoid arthritis (RA) and which RA patients go on to develop RA-LD, as well as how to prevent and treat the disease

Enrollment

New enrollment for this trial is temporarily paused

Who Can Participate

Individuals with rheumatoid arthritis (RA), interstitial lung disease (ILD) or lung fibrosis may be eligible to participate.

Age: 18+    Gender: Any Gender


Estimated Time Commitment

6 in-person visits, performed every year over 4 years



Payment & Reimbursement  

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Faduma Ahmed, Trial Coordinator

Faduma Ahmed
303.398.1285

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Pfizer

Co-Investigators


Request More Information

After limiting clinical research activity due to safety concerns about COVID-19, we are now restarting clinical research in stages. If you are interested in any of the clinical trials posted on our website, please request trial information. We will respond and share the timing for enrollment resuming. Learn More


*
*
*
*